JP2005504804A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504804A5
JP2005504804A5 JP2003530306A JP2003530306A JP2005504804A5 JP 2005504804 A5 JP2005504804 A5 JP 2005504804A5 JP 2003530306 A JP2003530306 A JP 2003530306A JP 2003530306 A JP2003530306 A JP 2003530306A JP 2005504804 A5 JP2005504804 A5 JP 2005504804A5
Authority
JP
Japan
Prior art keywords
weight
composition
dexamethasone
pharmaceutical composition
ciprofloxacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003530306A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504804A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/029373 external-priority patent/WO2003026671A1/en
Publication of JP2005504804A publication Critical patent/JP2005504804A/ja
Publication of JP2005504804A5 publication Critical patent/JP2005504804A5/ja
Pending legal-status Critical Current

Links

JP2003530306A 2001-09-21 2002-09-13 中耳感染を処置する方法 Pending JP2005504804A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32395101P 2001-09-21 2001-09-21
PCT/US2002/029373 WO2003026671A1 (en) 2001-09-21 2002-09-13 Method of treating middle ear infections

Publications (2)

Publication Number Publication Date
JP2005504804A JP2005504804A (ja) 2005-02-17
JP2005504804A5 true JP2005504804A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=23261416

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003530306A Pending JP2005504804A (ja) 2001-09-21 2002-09-13 中耳感染を処置する方法

Country Status (19)

Country Link
US (8) US20030139382A1 (cg-RX-API-DMAC7.html)
EP (1) EP1429780B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005504804A (cg-RX-API-DMAC7.html)
KR (1) KR20040035760A (cg-RX-API-DMAC7.html)
CN (1) CN1231218C (cg-RX-API-DMAC7.html)
AT (1) ATE313328T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002333671B2 (cg-RX-API-DMAC7.html)
BR (1) BR0212898A (cg-RX-API-DMAC7.html)
CA (1) CA2459930C (cg-RX-API-DMAC7.html)
CY (1) CY1104988T1 (cg-RX-API-DMAC7.html)
DE (1) DE60208216T2 (cg-RX-API-DMAC7.html)
DK (1) DK1429780T3 (cg-RX-API-DMAC7.html)
ES (1) ES2250739T3 (cg-RX-API-DMAC7.html)
FR (1) FR13C0012I2 (cg-RX-API-DMAC7.html)
MX (1) MXPA04002576A (cg-RX-API-DMAC7.html)
PL (1) PL212457B1 (cg-RX-API-DMAC7.html)
RU (1) RU2295346C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003026671A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200401847B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60208216T2 (de) * 2001-09-21 2006-06-29 Alcon Inc. Verfahren zur behandlung von mittelohrinfektionen
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US8084445B2 (en) * 2004-08-13 2011-12-27 Schering-Plough Animal Health Corporation Pharmaceutical formulation
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7993675B2 (en) * 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US20080139545A1 (en) * 2006-05-22 2008-06-12 Won-Taek Choe Formulation to treat ear infection
WO2008085913A1 (en) * 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US20090263345A1 (en) * 2008-01-28 2009-10-22 Foresight Biotherapeutics, Inc. Otic compositions for the treatment of infections of the internal and external ear in mammals
CN103417472B (zh) 2008-05-14 2018-01-02 奥德纳米有限公司 用于治疗耳部病症的控制释放皮质类固醇组合物和方法
EP2303254B1 (en) 2008-06-12 2019-10-30 Medtronic Xomed, Inc. Product for treating chronic wounds with an extracellular polymeric substance solvating system
US20100016450A1 (en) * 2008-07-21 2010-01-21 Otonomy, Inc. Controlled release delivery devices for the treatment of otic disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
MX2011000862A (es) * 2008-07-21 2011-03-15 Otonomy Inc Composiciones antimicrobianas de liberacion controlada y metodos para el tratamiento de trastornos oticos.
US20100086576A1 (en) * 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
KR20110123789A (ko) * 2009-03-03 2011-11-15 알콘 리서치, 리미티드 리셉터 티로신 키나제 저해(ＲＴＫｉ) 화합물을 눈에 전달하기 위한 약학 조성물
WO2010101989A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
US20120082627A1 (en) * 2009-06-08 2012-04-05 Otic Pharma Ltd. Otic foam formulations
US20120277199A1 (en) * 2009-10-21 2012-11-01 Otonomy, Inc. Modulation of Gel Temperature of Poloxamer-Containing Formulations
US10653133B2 (en) 2011-05-10 2020-05-19 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
ES2658995T3 (es) * 2012-12-26 2018-03-13 Otic Pharma Ltd. Composiciones farmacéuticas óticas espumables
KR20160047490A (ko) 2013-08-27 2016-05-02 오토노미, 인코포레이티드 소아 귀 질환의 치료
US20150119371A1 (en) * 2013-10-30 2015-04-30 Micro Labs Limited Topical pharmaceutical compositions of antibiotics and steroidal anti inflammatory agents
CA2954170A1 (en) * 2014-07-03 2016-01-07 Otonomy, Inc. Sterilization of ciprofloxacin composition
US9393243B1 (en) * 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions
WO2018053173A1 (en) 2016-09-16 2018-03-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
IT201900005280A1 (it) * 2019-04-05 2020-10-05 Ntc S R L Composizione otologica

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134718A (en) * 1963-12-12 1964-05-26 Schering Corp Pregna-1,4-dienes and compositions containing same
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US5223493A (en) * 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4686214A (en) * 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
DE3704907A1 (de) * 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
AU4201189A (en) * 1988-08-26 1990-03-23 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
SU1811833A1 (ru) * 1989-06-09 1993-04-30 Vladimir I Ivanov Способ введения лекарственных средств в ухо 2
DK0604570T3 (da) * 1991-09-17 1998-09-14 Alcon Lab Inc Præparater, der indeholder quinolon-antibiotika og sulfonat af polystyren
ES2065846B1 (es) 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
ES2078175B1 (es) 1993-12-31 1996-10-16 Cusi Lab Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
ES2079320B1 (es) * 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
DE69620136T2 (de) 1995-06-06 2002-08-01 Bayer Ag Antibakterielle präparate für die ohren ohne irritierende, sensibilisierende und ototoxische wirkungen
US5843930A (en) * 1995-06-06 1998-12-01 Bayer Corporation Method of treating otitis with ciprofloxacin-hydrocortisone suspension
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
ES2106680B1 (es) * 1995-08-03 1998-07-01 Vita Invest Sa Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
US6395746B1 (en) * 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
WO2000018404A1 (en) 1998-09-30 2000-04-06 Alcon Laboratories, Inc. Antibiotic compositions for treatment of the eye, ear and nose
AR020660A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
MXPA02003130A (es) * 1999-09-24 2004-04-21 Alcon Inc Formulaciones topicas en suspension que contienen ciprofloxacino y dexametasona.
DE60208216T2 (de) * 2001-09-21 2006-06-29 Alcon Inc. Verfahren zur behandlung von mittelohrinfektionen

Similar Documents

Publication Publication Date Title
JP2005504804A5 (cg-RX-API-DMAC7.html)
CA2459930A1 (en) Method of treating middle ear infections
US6599883B1 (en) Nasal delivery of xylitol
JP4748289B2 (ja) 点眼剤、眼科用組成物及び吸着抑制方法
CA2717605A1 (en) Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
ES2530719T3 (es) Formulaciones de oxicodona para ser administradas una vez al día
JP2011032293A (ja) シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物
JP2017019846A (ja) 点眼剤
JP2004514731A (ja) 眼薬送達のための可逆的ゲル化システム
KR20150011807A (ko) 자일리톨계 항-점액성 조성물과 관련 방법 및 조성물
AU2002333671A1 (en) Method of treating middle ear infections
JP2001187728A (ja) 眼科用組成物
JP2006528990A5 (cg-RX-API-DMAC7.html)
JP2025074239A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP2009509956A (ja) 非イオン性界面活性剤を使用して中耳内への経膜的薬物送達を促進する、中耳炎の処置および予防のための方法
CA2544139A1 (en) Suspension of loteprednol etabonate and tobramycin for topical ophthalmic use
JP2003520813A5 (cg-RX-API-DMAC7.html)
US20070212343A1 (en) Compositions for treatment of ear infections
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
CN101087607B (zh) 眼用组合物及使用其的方法
JP2001322936A (ja) 眼科用組成物
JP4849288B2 (ja) 点眼剤及び涙液膜の安定化剤
JPH0761937B2 (ja) コンタクトレンズの装用感及び安全性を改善するための点眼液
JP2005008596A (ja) 眼科用組成物
AU2017294686B2 (en) Use of xibornol as active agent in the treatment of viral infections